Immunologic Aspects of Dyslipidemia: a Critical Regulator of Adaptive Immunity and Immune Disorders

키워드

참고문헌 (108)

1. Hansson GK, "Inflammation, atherosclerosis, and coronary artery disease", N Engl J Med, 352, pp.1685~1695 (2005)
2. Weber C, "Atherosclerosis : current pathogenesis and therapeutic options", Nat Med, 17, pp.1410~1422 (2011)
3. Hansson GK, "The immune response in atherosclerosis : a double-edged sword", Nat Rev Immunol, 6, pp.508~519 (2006)
4. Weber C, "The multifaceted contributions of leukocyte subsets to atherosclerosis : lessons from mouse models", Nat Rev Immunol, 8, pp.802~815 (2008)
5. Grundtman C, "The autoimmune concept of atherosclerosis", Curr Opin Lipidol, 22, pp.327~334 (2011)
6. Hansson GK, "The immune system in atherosclerosis", Nat Immunol, 12, pp.204~212 (2011)
7. Duewell P, "NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals", Nature, 464, pp.1357~1361 (2010)
8. Stewart CR, "CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer", Nat Immunol, 11, pp.155~161 (2010)
9. Moore KJ, "Macrophages in the pathogenesis of atherosclerosis", Cell, 145, pp.341~355 (2011)
10. Nagy L, "Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma", Cell, 93, pp.229~240 (1998)
11. Chawla A, "PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation", Nat Med, 7, pp.48~52 (2001)
12. Moore KJ, "The role of PPAR-gamma in macrophage differentiation and cholesterol uptake", Nat Med, 7, pp.41~47 (2001)
13. Goodson N, "Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s", Ann Rheum Dis, 64, pp.1595~1601 (2005)
14. John H, "Cardiovascular co-morbidity in early rheumatoid arthritis", Best Pract Res Clin Rheumatol, 23, pp.71~82 (2009)
15. Nurmohamed MT, "Cardiovascular risk in rheumatoid arthritis", Autoimmun Rev, 8, pp.663~667 (2009)
16. Stamatelopoulos KS, "Atherosclerosis in rheumatoid arthritis versus diabetes : a comparative study", Arterioscler Thromb Vasc Biol, 29, pp.1702~1708 (2009)
17. Henseler T, "Disease concomitance in psoriasis", J Am Acad Dermatol, 32, pp.982~986 (1995)
18. Mallbris L, "Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients", Eur J Epidemiol, 19, pp.225~230 (2004)
19. Kremers HM, "Heart disease in psoriasis", J Am Acad Dermatol, 57, pp.347~354 (2007)
20. Kimball AB, "Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002", Dermatology, 217, pp.27~37 (2008)
21. Manzi S, "Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus : comparison with the Framingham Study", Am J Epidemiol, 145, pp.408~415 (1997)
22. Esdaile JM, "Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus", Arthritis Rheum, 44, pp.2331~2337 (2001)
23. Roman MJ, "Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus", N Engl J Med, 349, pp.2399~2406 (2003)
24. Morrow WJ, "Dietary fat and immune function. I. Antibody responses, lymphocyte and accessory cell function in(NZB x NZW)F1 mice", J Immunol, 135, pp.3857~3863 (1985)
25. Yumura W, "Dietary fat and immune function. II. Effects on immune complex nephritis in (NZB x NZW)F1 mice", J Immunol, 135, pp.3864~3868 (1985)
26. Winer S, "Obesity predisposes to Th17 bias", Eur J Immunol, 39, pp.2629~2635 (2009)
27. 전주연, "Obesity aggravates the joint inflammation in a collagen-induced arthritis model through deviation to Th17 differentiation", Experimental and Molecular Medicine, 44(7), pp.424~431 (2012), 생화학분자생물학회[DOI]
28. Naldi L, "Dietary factors and the risk of psoriasis. Results of an Italian case-control study", Br J Dermatol, 134, pp.101~106 (1996)
29. Rucević I, "The role of the low energy diet in psoriasis vulgaris treatment", Coll Antropol, 27(Suppl 1), pp.41~48 (2003)
30. Reich K, "Infliximab induction and maintenance therapy for moderate-to-severe psoriasis : a phase III, multicentre, double-blind trial", Lancet, 366, pp.1367~1374 (2005)
31. Chang SH, "Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor", J Biol Chem, 281, pp.35603~35607 (2006)
32. Ghazizadeh R, "Clinical improvement in psoriasis with treatment of associated hyperlipidemia", Am J Med Sci, 341, pp.394~398 (2011)
33. Yu HH, "Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia : a nationwide population-based cohort study", Atherosclerosis, 243, pp.11~18 (2015)
34. Tilley BJ, "Is higher serum cholesterol associated with altered tendon structure or tendon pain? A systematic review", Br J Sports Med, 49, pp.1504~1509 (2015)
35. Alvarez P, "Modulation of autoimmune arthritis severity in mice by apolipoprotein E(ApoE)and cholesterol", Clin Exp Immunol, 186, pp.292~303 (2016)
36. Westerterp M, "Cholesterol accumulation in dendritic cells links the inflammasome to acquired immunity", Cell Metab, 25, pp.1294~1304 (2017)
37. Gaddis DE, "Apolipoprotein AI prevents regulatory to follicular helper T cell switching during atherosclerosis", Nat Commun, 9, pp.1095~ (2018)
38. Ryu H, "Atherogenic dyslipidemia promotes autoimmune follicular helper T cell responses via IL-27", Nat Immunol, 19, pp.583~593 (2018)
39. Masson W, "Psoriasis and cardiovascular risk : a comprehensive review", Adv Ther, 37, pp.2017~2033 (2020)
40. Ito A, "Cholesterol accumulation in CD11c+ immune cells is a causal and targetable factor in autoimmune disease", Immunity, 45, pp.1311~1326 (2016)
41. Bagchi S, "CD1b-autoreactive T cells contribute to hyperlipidemia-induced skin inflammation in mice", J Clin Invest, 127, pp.2339~2352 (2017)
42. Huang J, "Tumor-induced hyperlipidemia contributes to tumor growth", Cell Reports, 15, pp.336~348 (2016)
43. Yang W, "Potentiating the antitumour response of CD8(+)T cells by modulating cholesterol metabolism", Nature, 531, pp.651~655 (2016)
44. Baek AE, "The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells", Nat Commun, 8, pp.864~ (2017)
45. Long J, "Lipid metabolism and carcinogenesis, cancer development", Am J Cancer Res, 8, pp.778~791 (2018)
46. Ma X, "Cholesterol negatively regulates IL-9-producing CD8+ T cell differentiation and antitumor activity", J Exp Med, 215, pp.1555~1569 (2018)
47. Ma X, "Cholesterol induces CD8(+)T cell exhaustion in the tumor microenvironment", Cell Metab, 30, pp.143~156 (2019)
48. Jacobs EJ, "Cholesterol-lowering drugs and advanced prostate cancer incidence in a large U. S. cohort", Cancer Epidemiol Biomarkers Prev, 16, pp.2213~2217 (2007)
49. Kumar AS, "Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users", Cancer Epidemiol Biomarkers Prev, 17, pp.1028~1033 (2008)
50. Longo J, "Statins as anticancer agents in the era of precision medicine", Clin Cancer Res, 26, pp.5791~5800 (2020)
51. Gabrilovich D, "Mechanisms and functional significance of tumour-induced dendritic-cell defects", Nat Rev Immunol, 4, pp.941~952 (2004)
52. Knight SC, "Specialized perinodal fat fuels and fashions immunity", Immunity, 28, pp.135~138 (2008)
53. Harimoto H, "Inactivation of tumor-specific CD8+ CTLs by tumor-infiltrating tolerogenic dendritic cells", Immunol Cell Biol, 91, pp.545~555 (2013)
54. Shi Y, "Suppression of vascular endothelial growth factor abrogates the immunosuppressive capability of murine gastric cancer cells and elicits antitumor immunity", FEBS J, 281, pp.3882~3893 (2014)
55. McDonnell AM, "Tumor-infiltrating dendritic cells exhibit defective cross-presentation of tumor antigens, but is reversed by chemotherapy", Eur J Immunol, 45, pp.49~59 (2015)
56. Herber DL, "Lipid accumulation and dendritic cell dysfunction in cancer", Nat Med, 16, pp.880~886 (2010)
57. Del Cornò M, "Visceral fat adipocytes from obese and colorectal cancer subjects exhibit distinct secretory and ω6 polyunsaturated fatty acid profiles and deliver immunosuppressive signals to innate immunity cells", Oncotarget, 7, pp.63093~63105 (2016)
58. Veglia F, "Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer", Nat Commun, 8, pp.2122~ (2017)
59. Iribarren C, "Cohort study of serum total cholesterol and in-hospital incidence of infectious diseases", Epidemiol Infect, 121, pp.335~347 (1998)
60. Grion CM, "Lipoproteins and CETP levels as risk factors for severe sepsis in hospitalized patients", Eur J Clin Invest, 40, pp.330~338 (2010)
61. Guirgis FW, "Cholesterol levels and long-term rates of community-acquired sepsis", Crit Care, 20, pp.408~ (2016)
62. Kaysen GA, "Lipid levels are inversely associated with infectious and all-cause mortality : international MONDO study results", J Lipid Res, 59, pp.1519~1528 (2018)
63. Alvarez MI, "Human genetic variation in VAC14 regulates Salmonella invasion and typhoid fever through modulation of cholesterol", Proc Natl Acad Sci U S A, 114, pp.E7746~ (2017)
64. Blanc M, "Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis", PLoS Biol, 9, pp.e1000598~ (2011)
65. Roselaar SE, "Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo", J Lipid Res, 39, pp.1740~1743 (1998)
66. Ludewig B, "Hypercholesterolemia exacerbates virus-induced immunopathologic liver disease via suppression of antiviral cytotoxic T cell responses", J Immunol, 166, pp.3369~3376 (2001)
67. Mogues T, "The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice", J Exp Med, 193, pp.271~280 (2001)
68. Orme IM, "Immunology and vaccinology of tuberculosis: can lessons from the mouse be applied to the cow?", Tuberculosis (Edinb), 81, pp.109~113 (2001)
69. Pearl JE, "Inflammation and lymphocyte activation during mycobacterial infection in the interferon-gamma-deficient mouse", Cell Immunol, 211, pp.43~50 (2001)
70. Vonk AG, "Apolipoprotein-E-deficient mice exhibit an increased susceptibility to disseminated candidiasis", Med Mycol, 42, pp.341~348 (2004)
71. Swain SL, "Expanding roles for CD4+ T cells in immunity to viruses", Nat Rev Immunol, 12, pp.136~148 (2012)
72. Martens GW, "Hypercholesterolemia impairs immunity to tuberculosis", Infect Immun, 76, pp.3464~3472 (2008)
73. Jiang H, "Retinoic acid and liver X receptor agonist synergistically inhibit HIV infection in CD4+ T cells by up-regulating ABCA1-mediated cholesterol efflux", Lipids Health Dis, 11, pp.69~ (2012)
74. Sloan JM, "MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cells", Cancer Gene Ther, 9, pp.946~950 (2002)
75. Wculek SK, "Dendritic cells in cancer immunology and immunotherapy", Nat Rev Immunol, 20, pp.7~24 (2020)
76. O'Shea D, "Changes in human dendritic cell number and function in severe obesity may contribute to increased susceptibility to viral infection", Int J Obes, 37, pp.1510~1513 (2013)
77. Shamshiev AT, "Dyslipidemia inhibits Toll-like receptor-induced activation of CD8alpha-negative dendritic cells and protective Th1 type immunity", J Exp Med, 204, pp.441~452 (2007)
78. Castrillo A, "Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism", Mol Cell, 12, pp.805~816 (2003)
79. Zhao GJ, "Antagonism of betulinic acid on LPS-mediated inhibition of ABCA1 and cholesterol efflux through inhibiting nuclear factor-kappaB signaling pathway and miR-33 expression", PLoS One, 8, pp.e74782~ (2013)
80. Tall AR, "Cholesterol, inflammation and innate immunity", Nat Rev Immunol, 15, pp.104~116 (2015)
81. Yvan-Charvet L, "Increased inflammatory gene expression in ABC transporter-deficient macrophages : free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions", Circulation, 118, pp.1837~1847 (2008)
82. Spann NJ, "Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses", Cell, 151, pp.138~152 (2012)
83. Packard RR, "CD11c(+)dendritic cells maintain antigen processing, presentation capabilities, and CD4(+)T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis", Circ Res, 103, pp.965~973 (2008)
84. Geyeregger R, "Liver X receptors regulate dendritic cell phenotype and function through blocked induction of the actin-bundling protein fascin", Blood, 109, pp.4288~4295 (2007)
85. Hanley TM, "PPARgamma and LXR signaling inhibit dendritic cell-mediated HIV-1 capture and trans-infection", PLoS Pathog, 6, pp.e1000981~ (2010)
86. Bruckner M, "Converse regulation of CCR7-driven human dendritic cell migration by prostaglandin E2 and liver X receptor activation", Eur J Immunol, 42, pp.2949~2958 (2012)
87. Scandella E, "Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells", Blood, 100, pp.1354~1361 (2002)
88. MacIver NJ, "Metabolic regulation of T lymphocytes", Annu Rev Immunol, 31, pp.259~283 (2013)
89. Geltink RI, "Unraveling the complex interplay between T cell metabolism and function", Annu Rev Immunol, 36, pp.461~488 (2018)
90. Bietz A, "Cholesterol metabolism in T cells", Front Immunol, 8, pp.1664~ (2017)
91. Reboldi A, "Cholesterol metabolism in innate and adaptive response", F1000 Res, 7, pp.1647~ (2018)
92. Chakrabarti R, "Interrelationships between mevalonate metabolism and the mitogenic signaling pathway in T lymphocyte proliferation", J Biol Chem, 266, pp.12216~12222 (1991)
93. Bensinger SJ, "LXR signaling couples sterol metabolism to proliferation in the acquired immune response", Cell, 134, pp.97~111 (2008)
94. Armstrong AJ, "ATP-binding cassette transporter G1 negatively regulates thymocyte and peripheral lymphocyte proliferation", J Immunol, 184, pp.173~183 (2010)
95. Michaels AJ, "Nuclear receptor LXRβ controls fitness and functionality of activated T cells", J Exp Med, 218, pp.e20201311~ (2021)
96. Cui G, "Liver X receptor(LXR)mediates negative regulation of mouse and human Th17 differentiation", J Clin Invest, 121, pp.658~670 (2011)
97. Lim SA, "Lipid signalling enforces functional specialization of Treg cells in tumours", Nature, 591, pp.306~311 (2021)
98. Zeng H, "mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function", Nature, 499, pp.485~490 (2013)
99. Perucha E, "The cholesterol biosynthesis pathway regulates IL-10 expression in human Th1 cells", Nat Commun, 10, pp.498~ (2019)
100. Kidani Y, "Sterol regulatory element-binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity", Nat Immunol, 14, pp.489~499 (2013)
101. Lee IK, "RORα regulates cholesterol metabolism of CD8+ T cells for anticancer immunity", Cancers (Basel), 12, pp.E1733~ (2020)
102. Ricker E, "Serine-threonine kinase ROCK2 regulates germinal center B cell positioning and cholesterol biosynthesis", J Clin Invest, 130, pp.3654~3670 (2020)
103. Chmielewski S, "STAT1 and IRF8 in vascular inflammation and cardiovascular disease : diagnostic and therapeutic potential", Int Rev Immunol, 35, pp.434~454 (2016)
104. A-Gonzalez N, "Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR", Immunity, 31, pp.245~258 (2009)
105. Joo H, "C-type lectin-like receptor LOX-1 promotes dendritic cell-mediated class-switched B cell responses", Immunity, 41, pp.592~604 (2014)
106. Shimabukuro-Vornhagen A, "Inhibition of protein geranylgeranylation specifically interferes with CD40-dependent B cell activation, resulting in a reduced capacity to induce T cell immunity", J Immunol, 193, pp.5294~5305 (2014)
107. Bibby JA, "Cholesterol metabolism drives regulatory B cell IL-10 through provision of geranylgeranyl pyrophosphate", Nat Commun, 11, pp.3412~ (2020)
108. Wang LW, "Epstein-Barr virus subverts mevalonate and fatty acid pathways to promote infected B-cell proliferation and survival", PLoS Pathog, 15, pp.e1008030~ (2019)

관련 논문AI추천